"uuid:ID","name","instanceType","label","identifier","id","description","text"
"53619b7e-8c4e-4862-acf0-69cfce3faf8b","Age Criteria","EligibilityCriterion","","1","EligibilityCriterion_1","The study age criterion","Subjects shall be between [min_age] and [max_age]"
"7f94f382-47ce-4eb4-8f9a-bc7b0e1fe811","Pop Criteria","EligibilityCriterion","","2","EligibilityCriterion_2","The study population criterion","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)"
"c5164ac9-8a9b-4165-b8f2-1456d5c5339f","Diag Criteria","EligibilityCriterion","","3","EligibilityCriterion_3","The study diagnosis criterion","[Activity1] score of 10 to 23"
"3ffe4bae-94ae-4f7d-ab87-1ad74963215f","Previous Criteria","EligibilityCriterion","","9","EligibilityCriterion_4","The previous xanomeline TTS criterion","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline."
